V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216734 | 20082634 | null | null | null | 2016-04-08 | 2016-04-08 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101201655 |
| 20216736 | 20082636 | 1.56 | 70 | Curative (C) | 2018-11-14 | 2018-12-05 | CAPECITABINE + MITOMYCIN + RT | N | Y | CAPECITABINE + MITOMYCIN + RT | 101472208 |
| 20216737 | 20082637 | 1.75 | 66.25 | Palliative (P) | null | 2017-06-23 | null | null | N | HCX | 100243419 |
| 20216738 | 20082638 | null | null | null | 2019-01-07 | 2019-01-14 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 101323451 |
| 20216739 | 20082639 | null | null | null | 2016-06-14 | 2016-07-15 | CAPECITABINE + MITOMYCIN + RT | N | null | CAPECITABINE + MITOMYCIN + RT | 100595646 |
| 20216742 | 20082641 | null | null | null | null | 2018-10-14 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101063161 |
| 20216747 | 20082643 | 1.7 | 63 | Neo-adjuvant (N) | null | 2016-04-27 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100873803 |
| 20216757 | 20082646 | 1.7 | 84 | null | null | 2020-01-23 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101332536 |
| 20216758 | 20082647 | null | null | null | 2016-08-24 | 2016-09-04 | null | null | null | CAPECITABINE + IRINOTECAN | 100281455 |
| 20216760 | 20082648 | null | null | null | null | 2018-02-16 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101849161 |
| 20216766 | 20082651 | 1.64 | 95.1 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-05 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101682157 |
| 20216769 | 20082653 | null | null | null | null | 2017-02-13 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100112061 |
| 20216771 | 20082654 | 1.86 | 65.8 | Palliative (P) | 2017-08-23 | 2017-08-23 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101213204 |
| 20216774 | 20082655 | null | null | null | null | 2019-05-21 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101287799 |
| 20216777 | 20082656 | 1.68 | 88.3 | Palliative (P) | 2019-01-21 | 2019-01-21 | null | null | N | CISPLATIN + ETOPOSIDE | 100173326 |
| 20216786 | 20082658 | null | null | null | null | 2017-07-30 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101392092 |
| 20216789 | 20082659 | 1.78 | 85 | null | 2019-01-30 | 2019-02-07 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | N | null | CETUXIMAB + IRINOTECAN + MDG | 100770057 |
| 20216790 | 20082660 | 1.65 | 88.3 | null | 2016-08-17 | 2016-09-06 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100675838 |
| 20216797 | 20082662 | 1.89 | 106 | Palliative (P) | 2019-10-25 | 2019-10-27 | LENVATINIB | 02 | N | LENVATINIB | 101069892 |
| 20216802 | 20082663 | null | null | null | 2017-07-22 | 2017-08-16 | null | null | null | CAPECITABINE + IRINOTECAN | 101599759 |
| 20216803 | 20082664 | 1.7 | 66.2 | Palliative (P) | 2019-01-16 | 2019-01-16 | CAPECITABINE + CISPLATIN + Trastuzumab | 2 | N | HCX | 100866111 |
| 20216810 | 20082667 | 1.83 | 71.4 | Neo-adjuvant (N) | 2016-09-01 | 2016-09-01 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101777697 |
| 20216812 | 20082668 | null | null | null | 2018-12-22 | 2019-01-09 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101257659 |
| 20216821 | 20082670 | 1.54 | 89.5 | Palliative (P) | null | 2017-01-08 | null | null | N | HCX | 101668537 |
| 20216826 | 20082672 | null | null | null | 2018-04-02 | 2018-04-06 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101813746 |
| 20216827 | 20082673 | 1.61 | null | Palliative (P) | 2019-05-03 | 2019-05-15 | null | null | Y | CISPLATIN + ETOPOSIDE | 100944095 |
| 20216828 | 20082674 | 1.76 | 69 | Palliative (P) | 2018-08-31 | 2018-09-11 | null | null | N | LENVATINIB | 100129015 |
| 20216829 | 20082675 | 1.65 | 78.7 | null | 2018-02-22 | 2018-02-24 | null | null | 2 | CAPECITABINE + IRINOTECAN | 100637701 |
| 20216837 | 20082679 | 1.75 | 84.35 | Curative (C) | 2019-09-12 | 2019-09-26 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101816299 |
| 20216843 | 20082681 | 1.7 | 77.6 | Neo-adjuvant (N) | null | 2020-03-10 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101680262 |
| 20216846 | 20082682 | null | null | null | null | 2017-12-07 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100217629 |
| 20216847 | 20082683 | null | null | null | 2016-05-08 | 2016-05-25 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100089768 |
| 20216848 | 20082684 | null | null | null | 2018-12-15 | 2019-01-13 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 100635156 |
| 20216852 | 20082685 | null | 84 | Palliative (P) | 2016-08-30 | 2016-08-30 | null | null | N | CISPLATIN + ETOPOSIDE | 100990357 |
| 20216854 | 20082686 | 1.82 | 63 | Palliative (P) | null | 2019-05-25 | null | null | N | LENVATINIB | 100202583 |
| 20216865 | 20082688 | 1.73 | 64.7 | Curative (C) | 2017-11-10 | 2017-11-15 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN + RT | 101333133 |
| 20216872 | 20082689 | null | null | null | null | 2019-04-06 | CAPECITABINE + IRINOTECAN | 2 | null | CAPECITABINE + IRINOTECAN | 100536361 |
| 20216879 | 20082691 | null | null | null | null | 2016-08-01 | null | null | null | LENVATINIB | 101694691 |
| 20216880 | 20082692 | null | null | null | 2016-06-14 | 2016-06-27 | null | null | null | HCX | 101329266 |
| 20216883 | 20082693 | null | null | null | null | 2017-01-28 | null | null | null | CISPLATIN + ETOPOSIDE | 101863039 |
| 20216886 | 20082694 | 1.84 | null | null | null | 2017-08-06 | null | null | Y | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101487291 |
| 20216887 | 20082695 | 1.73 | 93 | null | 2017-06-10 | 2017-06-15 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101647133 |
| 20216893 | 20082696 | 1.65 | 0 | Neo-adjuvant (N) | null | 2016-11-29 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 100922473 |
| 20216900 | 20082697 | 1.78 | 100 | Neo-adjuvant (N) | 2018-10-31 | 2018-12-03 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100365103 |
| 20216901 | 20082698 | 1.74 | 65.8 | Palliative (P) | null | 2016-03-06 | null | null | N | CISPLATIN + ETOPOSIDE | 101317856 |
| 20216903 | 20082699 | 1.8 | 73.2 | Palliative (P) | 2017-02-28 | 2017-03-01 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101035786 |
| 20216905 | 20082700 | 1.6 | 77.9 | Palliative (P) | 2017-07-13 | 2017-07-23 | null | null | N | CISPLATIN + ETOPOSIDE | 101603517 |
| 20216916 | 20082703 | 1.76 | 70.2 | Adjuvant (A) | 2018-03-05 | 2018-03-20 | CAPECITABINE + MITOMYCIN + RT | N | null | CAPECITABINE + MITOMYCIN + RT | 101157076 |
| 20216921 | 20082705 | 1.71 | 52 | null | null | 2019-10-20 | null | null | 2 | CAPECITABINE + IRINOTECAN | 101471933 |
| 20216922 | 20082706 | null | 85 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-08 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101802846 |